![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: John Wiley & Sons Inc
E-ISSN: 1532-6535|97|4|395-403
ISSN: 0009-9236
Source: CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.97, Iss.4, 2015-04, pp. : 395-403
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Profiling Solute Carrier Transporters in the Human Blood–Brain Barrier
CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 94, Iss. 6, 2013-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Blood–brain barrier: An impediment to neuropharmaceuticals
CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 4, 2015-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Brain targeting PBCA nanoparticles and the blood––brain barrier
By Wilson B
Nanomedicine, Vol. 4, Iss. 5, 2009-07 ,pp. :